International Conference on Metabolic Biomarkers and Clinical Applications
(ICMBCA-26)

13th December 2026 || Goa - India || Hybrid Mode

Proudly Organized by INRI

Join global experts to share ideas, connect, and innovate.
🎉 Coupon Copied Successfully!

Conference Session Tracks

The International Conference on Metabolic Biomarkers and Clinical Applications (ICMBCA), scheduled to be held on 13th December 2026 in Goa, India, features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of Metabolism.

Each track offers researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain. Every track is curated to encourage knowledge sharing, collaboration and meaningful discussion.

All Session Tracks
  • Track 01 – Advancements in Metabolic Biomarker Discovery
    This session will explore the latest methodologies in the identification and validation of metabolic biomarkers. Emphasis will be placed on innovative techniques that enhance biomarker discovery for various diseases. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 02 – Molecular Diagnostics in Metabolic Disorders
    This track focuses on the application of molecular diagnostic tools in the assessment of metabolic disorders. Participants will discuss the integration of these tools into clinical practice for improved patient outcomes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 03 – Translational Research in Metabolism
    This session will highlight the critical role of translational research in bridging laboratory findings with clinical applications in metabolism. Case studies will illustrate successful transitions from bench to bedside. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 04 – Clinical Applications of Metabolic Biomarkers
    This track will examine the practical applications of metabolic biomarkers in clinical settings. Discussions will include their role in diagnosis, prognosis, and monitoring of treatment efficacy. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 05 – Laboratory Techniques for Metabolic Profiling
    This session will cover cutting-edge laboratory techniques used for metabolic profiling. Participants will gain insights into methodologies that enhance the accuracy and reliability of metabolic assessments. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 06 – Patient Care Strategies Informed by Metabolic Insights
    This track will focus on how metabolic insights can inform patient care strategies. Presentations will highlight personalized approaches to treatment based on metabolic profiling. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 07 – Therapeutic Strategies Targeting Metabolic Pathways
    This session will explore novel therapeutic strategies aimed at metabolic pathways involved in disease mechanisms. Discussions will include pharmacological and non-pharmacological interventions. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 08 – Disease Mechanisms Linked to Metabolic Dysregulation
    This track will delve into the underlying disease mechanisms associated with metabolic dysregulation. Research findings will be presented to elucidate the connections between metabolism and various health conditions. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 09 – Integration of Metabolic Biomarkers in Clinical Trials
    This session will discuss the role of metabolic biomarkers in the design and implementation of clinical trials. Emphasis will be placed on how these biomarkers can enhance trial outcomes and patient stratification. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 10 – Ethical Considerations in Metabolic Biomarker Research
    This track will address the ethical implications surrounding metabolic biomarker research and its clinical applications. Discussions will focus on patient consent, data privacy, and the responsible use of biomarker information. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 16 – Peace, Justice and Strong Institutions
  • Track 11 – Future Directions in Metabolism Research
    This session will explore emerging trends and future directions in metabolism research. Participants will discuss potential breakthroughs and their implications for clinical practice and patient care. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.
  • SDG 3 SDG 3
    Good Health and Well-being
  • SDG 4 SDG 4
    Quality Education
  • SDG 9 SDG 9
    Industry, Innovation and Infrastructure
  • SDG 16 SDG 16
    Peace, Justice and Strong Institutions

Need Assistance?

If you need any clarification on the session tracks or support with your submission, please feel free to reach out to us:

Email: [email protected]

Phone: +91 9677007228